AzTrials
AzTrials

Anorexia NervosaEarly Phase 1vFBTNCT04678843

Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond

A Early Phase 1 study testing Virtual Family-Based Treatment in people with Anorexia Nervosa, run by Jennifer Couturier at 4 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The COVID-19 pandemic has had detrimental effects on mental health. Individuals with eating disorders (EDs) are no exception, exhibiting increased symptoms and exacerbated feelings of isolation and anxiety. Read more about this study

Who is it for?
Ages 10 to 18 years
Conditions the study is for
Anorexia Nervosa
What is being tested?
Virtual Family-Based Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
4 sitesCanada
Study dates
9 Feb 2021to 1 Aug 2021
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Youth must be under 18 years of age in order to participate
  • Youth must have a diagnosis of Anorexia Nervosa in order to participate
  • Must have the capacity to write, speak, and understand English
  • Must have access to a computer and the internet.

Who cannot join

  • Individuals 18 years of age and older are unable to participate
  • Youth without a diagnosis of Anorexia Nervosa are unable to participate
  • Individuals who cannot write, speak and understand English are unable to participate
  • Individuals who do not have access to a computer and the internet are unable to participate

Trial locations and contacts

4 sites in 1 country.

Canada4 sites
  • Southlake Regional Health Centre

    Newmarket, Ontario, L3Y 2P9

  • St. Joseph's Care Group

    Thunder Bay, Ontario, P7B 5G7

  • North York General Hospital

    Toronto, Ontario, M2J 0B1

  • CMHA Waterloo Wellington

    Waterloo, Ontario, N2J 4M1

Other trials in Canada

About this study

The COVID-19 pandemic has had detrimental effects on mental health. Individuals with eating disorders (EDs) are no exception, exhibiting increased symptoms and exacerbated feelings of isolation and anxiety. Across Canada, in-person outpatient services have been quickly replaced with virtual care, yet practitioners and patients have noted substantial challenges in adapting ED-related care virtually. Given the success of our previous research on Family-Based Treatment (FBT) for EDs, as well as the rapid transition to virtual care during COVID-19, there is an urgent need to adapt FBT to virtual formats and adopt it in the ED network. Using a multi-site case study with a mixed method pre/post design, this study aims to examine the implementation of virtual FBT (vFBT) as well as its impact within six ED programs in Ontario, building on the investigator's previous work, and further developing capacity in the system. The investigator will develop implementation teams at each site and provide a virtual training workshop on vFBT, with ongoing consultation during initial implementation. The investigator proposes to examine implementation success by studying fidelity to vFBT, as well as team and patient/family experience with virtual care, and patient outcomes. These findings for virtual care will not only be important in the COVID-19 context but are also vital in the North, where access to specialized services is extremely limited.

Being tested
Virtual Family-Based Treatment
Keywords
anorexia nervosa, youth, adolescents, eating disorders, family-based treatment
Medical subject headings
Anorexia Nervosa, Feeding and Eating Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Family-Based TreatmentBehavioural

    Treatment involving the youth/adolescent who has been diagnosed with anorexia nervosa and their family, delivered virtually via videoconferencing.

Study groups in NCT04678843
Study groupRoleWhat they receive
Virtual Family-Based TreatmentExperimentalFamily-based treatment is the gold standard treatment for youth and adolescents with anorexia nervosa. A therapist works with the family to help parents take charge of the process of re-feeding their child, and with progress this control is gradually given back to the youth/adolescent. Other developmental issues are discussed in order to help the youth/adolescent get back to normal development.
Receives: Behavioral: Virtual Family-Based Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Key components of FBT

    Measured by a self-report questionnaire entitled Key Measure of Therapist Behaviours and Self-Efficacy in FBT (an indicator of therapist adherence to the key components of standard FBT within the vFBT model)

    Measured: Completed after session 4 of treatment, approximately 4 months

  2. Fidelity

    Fidelity to vFBT, measured by FBT fidelity ratings of the first four sessions of vFBT using the FBT Fidelity and Adherence Check (experts in FBT fidelity rating will rate the recordings).

    Measured: Completed after the session 4 of treatment, approximately 4 months

Secondary outcomes (6)
  1. Qualitative experience of participants

    Experiences of the therapists, medical practitioners, administrators, and families in vFBT, qualitatively measured during semi-structured focus groups

    Measured: Completed after session 4 of treatment, approximately 4 months

  2. Change in Weight

    Weight will be measured in kilograms.

    Measured: At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.

  3. Change in Number of Binge/Purge Episodes

    The number of binge/purge episodes each week will be recorded by patients/their families.

    Measured: At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.

  4. Therapists' Change in Readiness

    The Brief Individual Readiness to Change Scale will indicate how ready therapists feel they are to change. Higher scores indicate greater readiness to use research-based direct service techniques. Minimum score is 0, maximum score is 20.

    Measured: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)

  5. Therapists' Change in Attitudes about Evidence Based Practice

    Their attitudes about evidence-based practice will be assessed using the Evidence Based Practice Attitudes Scale (EBPAS). The subscales include requirements, appeal, openness and divergence. The score for each subscale is created by computing a mean score for the items that load on a given subscale. Minimum score for each subscale is 0, maximum score for each subscale is 4.

    Measured: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)

  6. Therapists' Change in Confidence related to the Intervention

    Their confidence related to the intervention will be assessed by administering an adapted version of the Perceived Attributes of the Principles of Effectiveness Scale (MPAS). Higher scores are indicative of more favorable perception for FBT content. The minimum score is 18, the maximum score is 90.

    Measured: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2020
  2. Study start9 Feb 2021
  3. Primary completion31 Jul 2021
  4. Study completion1 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
We study a blended implementation approach for Family-Based Treatment delivered via videoconferencing (FBT-V)
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04678843
Sponsor's protocol ID
12722
Acronym
vFBT
Status last verified
Sep 2022
First submitted
17 Dec 2020
Last updated
10 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Couturier J, Pellegrini D, Grennan L, Nicula M, Miller C, Agar P, Webb C, Anderson K, Barwick M, Dimitropoulos G, Findlay S, Kimber M, McVey G, Lock J. Multidisciplinary implementation of family-based treatment delivered by videoconferencing (FBT-V) for adolescent anorexia nervosa during the COVID-19 pandemic. Transl Behav Med. 2023 Feb 28;13(2):85-97. doi: 10.1093/tbm/ibac086.

    PubMed 36327378
  • Couturier J, Pellegrini D, Grennan L, Nicula M, Miller C, Agar P, Webb C, Anderson K, Barwick M, Dimitropoulos G, Findlay S, Kimber M, McVey G, Paularinne R, Nelson A, DeGagne K, Bourret K, Restall S, Rosner J, Hewitt-McVicker K, Pereira J, McLeod M, Shipley C, Miller S, Boachie A, Engelberg M, Martin S, Holmes-Haronitis J, Lock J. A qualitative evaluation of team and family perceptions of family-based treatment delivered by videoconferencing (FBT-V) for adolescent Anorexia Nervosa during the COVID-19 pandemic. J Eat Disord. 2022 Jul 26;10(1):111. doi: 10.1186/s40337-022-00631-9.

    PubMed 35883167
  • Couturier J, Pellegrini D, Miller C, Agar P, Webb C, Anderson K, Barwick M, Dimitropoulos G, Findlay S, Kimber M, McVey G, Lock J. Adapting and adopting highly specialized pediatric eating disorder treatment to virtual care: a protocol for an implementation study in the COVID-19 context. Implement Sci Commun. 2021 Apr 8;2(1):38. doi: 10.1186/s43058-021-00143-8.

    PubMed 33832543

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Virtual Family-Based Treatment in people with Anorexia Nervosa, run by Jennifer Couturier at 4 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Key components of FBT (time frame: Completed after session 4 of treatment, approximately 4 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04678843, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in